Start-Up Previews (3/06)
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Cardiac Regeneration Start-Ups Look to Repair, not Replace, features profiles of Arteriocyte, Celladon, NanoCor Therapeutics and Theregen. Plus these Start-Up Across Health Care: Alder Biopharmaceuticals, Endotis, Novelix and VaxInnate.
You may also be interested in...
Following a €2.5m award from the European Commission’s EIC Accelerator Program, Paris based CorWave has become the first EU company to obtain EIC fund investment. The company is developing a new pulsatile LVAD.
The UK biotech is set for a NASDAQ launch which could propel to its first commercial launch by 2022
Biohaven’s investigational glutamate modulator troriluzole did not improve symptoms in patients with mild-to-moderate disease, adding to the list of failures in Alzheimer’s disease, as well as for the product itself.